Douglas M. Chalmers

1.1k total citations · 1 hit paper
8 papers, 901 citations indexed

About

Douglas M. Chalmers is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, Douglas M. Chalmers has authored 8 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Gastroenterology and 2 papers in Epidemiology. Recurrent topics in Douglas M. Chalmers's work include Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (4 papers) and Microscopic Colitis (2 papers). Douglas M. Chalmers is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (4 papers) and Microscopic Colitis (2 papers). Douglas M. Chalmers collaborates with scholars based in United Kingdom, Netherlands and Australia. Douglas M. Chalmers's co-authors include Filip Baert, Geert D’Haens, T Schaible, Paul Rutgeerts, Sander van Deventer, Karel Geboes, Anthony Axon, Nic P. Mapstone, Ian Drake and Michael F. Dixon and has published in prestigious journals such as Gastroenterology, British Journal Of Nutrition and Carcinogenesis.

In The Last Decade

Douglas M. Chalmers

8 papers receiving 861 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1999 585 citations Geert D’Haens, Sander van Deventer et al. Gastroenterology profile →

Peers

Countries citing papers authored by Douglas M. Chalmers

Since Specialization

Citations

This map shows the geographic impact of Douglas M. Chalmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas M. Chalmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas M. Chalmers more than expected).

Fields of papers citing papers by Douglas M. Chalmers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas M. Chalmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas M. Chalmers. The network helps show where Douglas M. Chalmers may publish in the future.

Co-authorship network of co-authors of Douglas M. Chalmers

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas M. Chalmers. A scholar is included among the top collaborators of Douglas M. Chalmers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas M. Chalmers. Douglas M. Chalmers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Risk Factors, DNA Damage, and Disease Progression in Barrett's Esophagus 2005 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Laura J. Hardie, Yun Yun Gong, Simon Dexter, Douglas M. Chalmers, Keith M. Harris, Christopher P. Wild	63
2	Cost-effectiveness and long-term impact of Helicobacter pylori ???test and treat??? service in reducing open access endoscopy referrals 2004 ·European Journal of Gastroenterology & Hepatology ·Aravamuthan Sreedharan, (unknown), (unknown), Luigi Gatta, Douglas M. Chalmers, Anthony Axon, Paul Moayyedi	8
3	Antioxidant vitamin supplements do not reduce reactive oxygen species activity inHelicobacter pylorigastritis in the short term 2002 ·British Journal Of Nutrition ·Simon Everett, Ian Drake, Kay White, Nic P. Mapstone, Douglas M. Chalmers, C.J. Schorah, Anthony Axon	32
4	Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial breakdown → 1999 ·Gastroenterology ·Geert D’Haens, Sander van Deventer, (unknown), Douglas M. Chalmers, (unknown), Filip Baert, (unknown), T Schaible, Karel Geboes, Paul Rutgeerts	585
5	The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia 1999 ·European Journal of Gastroenterology & Hepatology ·Paul Moayyedi, (unknown), (unknown), (unknown), Douglas M. Chalmers, Anthony Axon	28
6	Do patients need to fast for a 13C-urea breath test? 1997 ·European Journal of Gastroenterology & Hepatology ·Paul Moayyedi, David Braunholtz, (unknown), (unknown), D S Tompkins, Nic P. Mapstone, Suzanne Mason, Anthony Dowell, (unknown), Douglas M. Chalmers, A. T. R. Axon	42
7	Comparison of One or Two Weeks of Lansoprazole, Amoxicillin, and Clarithromycin in the Treatment of Helicobacter pylori 1996 ·Helicobacter ·Paul Moayyedi, (unknown), (unknown), D S Tompkins, Michael F. Dixon, Douglas M. Chalmers, Anthony Axon	32
8	Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals 1996 ·Carcinogenesis ·Ian Drake, Michael J. Davies, Nic P. Mapstone, Michael F. Dixon, C.J. Schorah, Kay White, Douglas M. Chalmers, Anthony Axon	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact